000			01637 a2200433 4500
005			20250515184957.0
264		0	_c20091202
008			200912s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/1471-2407-9-322 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchrohl, Anne-Sofie
245	0	0	_aTumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study. _h[electronic resource]
260			_bBMC cancer _cSep 2009
300			_a322 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnthracyclines _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCohort Studies
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aFluorouracil _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLymphatic Metastasis
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPremenopause
650	0	4	_aRetrospective Studies
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism
650	0	4	_aTreatment Outcome
700	1		_aLook, Maxime P
700	1		_aMeijer-van Gelder, Marion E
700	1		_aFoekens, John A
700	1		_aBrünner, Nils
773	0		_tBMC cancer _gvol. 9 _gp. 322
856	4	0	_uhttps://doi.org/10.1186/1471-2407-9-322 _zAvailable from publisher's website
999			_c19142711 _d19142711